The latest report by IMARC Group, titled “Isothermal Nucleic Acid Amplification Technology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032“, The global isothermal nucleic acid amplification technology (INAAT) market size reached US$ 3.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 7.9 Billion by 2032, exhibiting a growth rate (CAGR) of 10.8% during 2024-2032.
Novel isothermal technology for amplifying nucleic acids operates at a consistent temperature, diverging from traditional methods. This innovative approach is gaining traction in diagnostics, particularly for identifying infectious agents by targeting nucleic acids. Its attributes include simplicity, speed, and cost-effectiveness, making it well-suited for point-of-care testing in limited-resource environments. Various techniques fall under this umbrella, such as loop-mediated isothermal amplification (LAMP), nucleic acid sequence-based amplification (NASBA), strand displacement amplification (SDA), rolling circle amplification (RCA), and recombinase polymerase amplification (RPA). Notable benefits encompass compact sensors, on-the-spot diagnosis capabilities, and alignment with the World Health Organization’s criteria for ensuring rapid and accurate molecular diagnostics.
For an in-depth analysis, you can refer sample copy of the report:https://www.imarcgroup.com/isothermal-nucleic-acid-amplification-technology-market/requestsample
Isothermal Nucleic Acid Amplification Technology Market Trends and Drivers:
The rapid growth of the global market for isothermal nucleic acid amplification technology is mainly driven by the increasing demand for quick and accurate molecular diagnostics. Isothermal amplification methods provide significant benefits over traditional PCR by consistently amplifying nucleic acids at a constant temperature, eliminating the need for expensive thermal cyclers and complex lab setups. This makes them particularly attractive in areas with limited resources and infrastructure for advanced molecular diagnostics. Additionally, the rising prevalence of infectious diseases caused by viruses, bacteria, and parasites is driving the need for effective and accessible diagnostic solutions, further fueling market expansion.
Isothermal nucleic acid amplification techniques show promise in detecting infectious pathogens, enabling rapid and precise diagnoses that support market growth. Known for their high sensitivity and specificity, these methods allow for the detection of targets with minimal false-positive or false-negative results. Moreover, the ability to perform quick on-site diagnostics using isothermal amplification technology enhances patient care, infection control, and disease monitoring, contributing to market progress.
Furthermore, the increasing focus on personalized medicine and precision diagnostics is increasing the demand for advanced molecular technologies that can identify specific genetic variations or mutations associated with various conditions, driving a positive market trend.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Instruments
- Reagents
Breakup by Technology:
- Helicase-Dependent Amplification (HDA)
- Nicking Enzyme Amplification Reaction (NEAR)
- Loop-Mediated Isothermal Amplification (LAMP)
- Strand Displacement Amplification (SDA)
- Nucleic Acid Sequence-Based Amplification (NASBA)
- Transcription Mediated Amplification (TMA)
- Single Primer Isothermal Amplification (SPIA)
- Others
Breakup by Application:
- Infectious Disease Diagnosis
- Hepatitis
- CT/NG
- HIV
- Influenza
- Others
- Blood Screening
- Others
Breakup by End-User:
- Hospitals
- Diagnostic Laboratories
- Research Laboratories
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- bioMérieux SA
- Becton
- Dickinson and Company
- Eiken Chemical Co. Ltd.
- Hologic Inc., Meridian Bioscience Inc.
- OptiGene Limited
- Thermo Fisher Scientific Inc.
- Tecan Trading AG
- Ustar Biotechnologies Ltd.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
